Armstrong, Wrigley announce executive actions to ban unregulated drug kratom amid growing concerns - governor.nd.gov
North Dakota has announced an executive action to ban unregulated kratom, impacting its availability and legality for businesses dealing with controlled substances.
Aforeworn detected this change in the Pharmacy & Controlled Substances space on September 6, 2026 and published this briefing so affected operators are forewarned rather than caught off guard. It is rated High urgency. All pharmacies and businesses involved in the sale or distribution of kratom in North Dakota. should confirm how it applies to their specific situation before acting. There is a time constraint attached: Immediate effect upon announcement.. Acting after that point can mean penalties, a lapsed licence, or lost eligibility — exactly the kind of surprise Aforeworn exists to prevent. Aforeworn monitors Pharmacy & Controlled Substances continuously and turns every detected change into a plain-English briefing like this one, so you always know first. Forewarned is forearmed.
What changed
Kratom is now banned, affecting its sale and distribution.
Who it affects
All pharmacies and businesses involved in the sale or distribution of kratom in North Dakota.
What you must do
Cease all sales and distribution of kratom products immediately.
Deadline
Immediate effect upon announcement.
Never miss a change like this again
Aforeworn watches Pharmacy & Controlled Substances around the clock and alerts you the moment a rule moves — with a plain-English brief on what to do.
Start your free trialRelated changes in Pharmacy & Controlled Substances
- AstraZeneca Sues to Overturn New Mexico 340B Drug Discount Law - news.bloomberglaw.com
- Whitmer signs Michigan opioid and public health bills - Huron Daily Tribune
- Utah opens applications for another medical cannabis license - mjbizdaily.com
- UPDATED: Armstrong signs bill banning synthetic kratom, restricting natural kratom to 21 and older - governor.nd.gov
- State excludes veterinarians from prescription drug database requirement - Cronkite News